Jillian B. Thomsen, SVP & Chief Accounting Officer at NEKTAR THERAPEUTICS (NKTR), sold 2,006 shares at $4.76 ($10K) on 2022-08-16, disclosed to the SEC on 2022-08-17.
Seasonal sale ($10k) by SVP & Chief Accounting Officer — this insider has traded NKTR in August in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| NKTR | SELL | 2022-05-17 | $23K | — | Filing → |
| NKTR | SELL | 2022-02-18 | $26K | — | Filing → |
| NKTR | SELL | 2021-11-17 | $177K | — | Filing → |